Ypsomed Holding AG (YPHDF)
501.00
0.00 (0.00%)
USD |
OTCM |
Sep 02, 16:00
Ypsomed Research and Development Expense (Annual) : 49.86M for March 31, 2026
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| March 31, 2026 | 49.86M |
| March 31, 2025 | 37.84M |
| March 31, 2024 | 34.38M |
| March 31, 2023 | |
| March 31, 2022 | |
| March 31, 2021 | |
| March 31, 2020 | 42.56M |
| March 31, 2019 | 42.30M |
| March 31, 2018 | 41.73M |
| March 31, 2017 | 30.55M |
| March 31, 2016 | 27.31M |
| March 31, 2015 | 29.85M |
| March 31, 2014 | 25.41M |
| Date | Value |
|---|---|
| March 31, 2013 | 25.15M |
| March 31, 2012 | 28.58M |
| March 31, 2011 | 27.09M |
| March 31, 2010 | 6.888M |
| March 31, 2009 | 9.493M |
| March 31, 2008 | 13.16M |
| March 31, 2007 | 17.71M |
| March 31, 2006 | 13.50M |
| March 31, 2005 | 11.67M |
| March 31, 2004 | 5.025M |
| March 31, 2003 | 3.081M |
| March 31, 2002 | 0.4696M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Metall Zug AG | 31.41M |
| Alcon AG | 990.00M |
| Straumann Holding AG | -- |
| Medacta Group SA | 14.54M |
| Medartis Holding AG | 34.63M |